zm 230487 has been researched along with thromboxane b2 in 1 studies
Studies (zm 230487) | Trials (zm 230487) | Recent Studies (post-2010) (zm 230487) | Studies (thromboxane b2) | Trials (thromboxane b2) | Recent Studies (post-2010) (thromboxane b2) |
---|---|---|---|---|---|
17 | 0 | 0 | 7,483 | 715 | 485 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buckner, CK; Dea, DM; DeHaas, CJ; Krell, RD; Kusner, EJ; Marks, RL | 1 |
1 other study(ies) available for zm 230487 and thromboxane b2
Article | Year |
---|---|
The 5-lipoxygenase inhibitors ZD2138 and ZM230487 are potent and selective inhibitors of several antigen-induced guinea-pig pulmonary responses.
Topics: Airway Resistance; Animals; Antigens; Cyclooxygenase Inhibitors; Guinea Pigs; Histamine Release; Indoles; Leukotrienes; Lipoxygenase Inhibitors; Lung; Male; Phospholipases A; Phospholipases A2; Pyrans; Quinolones; Thromboxane B2; Thromboxane-A Synthase | 1994 |